Clinical Trial Update: Quetiapine in Social Anxiety Disorder [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating quetiapine for social anxiety disorder, sponsored by Duke University, has been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Duke University | Conditions: Social Anxiety Disorder | Phase 2, Phase 3 | Status: COMPLETED